| Noncolorectal Gastrointestinal Cancer |
1 |
1 |
| Cancer |
0 |
0.83 |
| Biologic Therapy |
0 |
0.81 |
| Colorectal Cancer |
0 |
0.75 |
| Hepatocellular Carcinoma |
0 |
0.75 |
| Toxicology |
0 |
0.7 |
| Gastric Cancer |
0 |
0.65 |
| Refractory |
0 |
0.37 |
| Tumor |
0 |
0.28 |
| VEGF Inhibitor |
0 |
0.26 |
| Patient Safety |
0 |
0.21 |
| Chemotherapy |
0 |
0.18 |
| Gastrointestinal Stromal Tumor |
0 |
0.18 |
| Hospital |
0 |
0.18 |
| Quality of Life |
0 |
0.18 |
| Vascular Endothelial Growth Factor |
0 |
0.18 |
| Diarrhea |
0 |
0.11 |
| Adverse Effects |
0 |
0.09 |
| Angiogenesis |
0 |
0.09 |
| Gastroenteritis |
0 |
0.09 |
| Prognosis |
0 |
0.09 |
| Radiation Therapy |
0 |
0.09 |
| Surgical Oncology |
0 |
0.09 |